Artiva Biotherapeutics, Inc. Increase (Decrease) in Other Noncurrent Assets
Artiva Biotherapeutics, Inc. (ARTV) reported Increase (Decrease) in Other Noncurrent Assets of $351.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-06
- Artiva Biotherapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was $40.00K.
- Artiva Biotherapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was $380.00K.
- Artiva Biotherapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-06-30 was $25.00K.
- Artiva Biotherapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-03-31 was -$254.00K.
- Artiva Biotherapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2025 was $191.00K.
- Artiva Biotherapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2024 was -$125.00K.
- Artiva Biotherapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2023 was -$139.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $351.00K 10-Q · filed 2026-08-06 | |||
| 2025-12-31 | $40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $420.00K derived: sum of 2 quarters · filed 2026-03-10 | $445.00K derived: sum of 3 quarters · filed 2026-08-06 | $191.00K 10-K · filed 2026-03-10 |
| 2025-09-30 | $380.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $405.00K derived: sum of 2 quarters · filed 2026-08-06 | $151.00K 10-Q · filed 2025-11-12 | $120.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$229.00K 10-Q · filed 2026-08-06 | -$260.00K derived: sum of 3 quarters · filed 2026-08-06 | -$292.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$254.00K 10-Q · filed 2026-05-08 | -$285.00K derived: sum of 2 quarters · filed 2026-05-08 | -$317.00K derived: sum of 3 quarters · filed 2026-05-08 | -$348.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$63.00K derived: sum of 2 quarters · filed 2026-03-10 | -$94.00K derived: sum of 3 quarters · filed 2026-03-10 | -$125.00K 10-K · filed 2026-03-10 |
| 2024-09-30 | -$32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$63.00K derived: sum of 2 quarters · filed 2025-11-12 | -$94.00K 10-Q · filed 2025-11-12 | -$139.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$62.00K 10-Q · filed 2025-08-06 | -$107.00K derived: sum of 3 quarters · filed 2025-08-06 | -$138.00K derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | -$31.00K 10-Q · filed 2025-05-08 | -$76.00K derived: sum of 2 quarters · filed 2025-05-08 | -$107.00K derived: sum of 3 quarters · filed 2025-05-08 | |
| 2023-12-31 | -$45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$76.00K derived: sum of 2 quarters · filed 2025-03-24 | -$139.00K 10-K · filed 2025-03-24 | |
| 2023-09-30 | -$31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$94.00K 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | -$63.00K 10-Q · filed 2024-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |